Q2 2024

Filed Dec 23, 2025 · 10-Q · 541 days after period end · 0001493152-25-028946

Q2 2024 · 10-Q

Revenue

$51.71K

no prior Q2 2023 on file

Net Income

-$367.14K

N/M vs Q2 2023

EPS Diluted

$0.00

— vs Q2 2023

Gross Profit$54,845—

Operating Income

Same quarter

Metric	Q2 2024	Q2 2023	Q2 2022	Q2 2021
Revenue	$51.71K	—	$28.43K	$30.46K
Net Income	-$367.14K	-$279.25K	-$645.80K	$3.36M
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR